TD Cowen Downgrades Bio-Techne Corp. (TECH) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts TECH Hot Sheet
Price: $72.69 +0.03%
Rating Summary:
6 Buy, 15 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 21 | New: 13
Rating Summary:
6 Buy, 15 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 21 | New: 13
Join SI Premium – FREE
TD Cowen analyst Kyle Boucher downgraded Bio-Techne Corp. (NASDAQ: TECH) from Buy to Hold with a price target of $73.00.
For an analyst ratings summary and ratings history on Bio-Techne Corp. click here. For more ratings news on Bio-Techne Corp. click here.
Shares of Bio-Techne Corp. closed at $71.00 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Super Micro Computer (SMCI) Tops Q1 EPS by 58c, Offers Guidance
- Hagerty Inc. (HGTY) PT Raised to $20 at Oppenheimer
- Solar Capital (SLRC) Reports In-Line Q3 EPS
Create E-mail Alert Related Categories
DowngradesRelated Entities
Cowen & Co, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
